EVALUATING THE IMPLEMENTATION OF TRACHOMOA TREATMENT GUIDELINES IN AUSTRALIA

被引:0
|
作者
Kelaher, M. [1 ]
Ferdinand, A. [1 ]
Taylor, H. [1 ]
机构
[1] Univ Melbourne, Melbourne, Vic, Australia
关键词
D O I
10.1136/jech.2011.142976p.66
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
引用
收藏
页码:A453 / A453
页数:1
相关论文
共 50 条
  • [1] Development, Implementation, and Evaluation of Treatment Guidelines for Herpes Simplex Keratitis in Sydney, Australia
    Cabrera-Aguas, Maria
    Kerdraon, Yves
    Symes, Richard J.
    McCluskey, Peter
    Samarawickrama, Chameen
    Rawlinson, William
    Watson, Stephanie L.
    CORNEA, 2020, 39 (07) : 834 - 840
  • [2] Implementation of guidelines for treatment
    El Ekiaby, M.
    HAEMOPHILIA, 2010, 16 : 11 - 11
  • [3] AUSTRALIA: FURTHER IMPLEMENTATION OF FCTC 5.3 GUIDELINES
    Baker, John
    TOBACCO CONTROL, 2020, 29 (01) : 4 - 5
  • [4] Criteria for evaluating treatment guidelines
    Reed, GM
    AMERICAN PSYCHOLOGIST, 2002, 57 (12) : 1052 - 1059
  • [5] GUIDELINES FOR THE IMPLEMENTATION OF ODOR TREATMENT
    PERRYMAN, R
    CHEMISTRY & INDUSTRY, 1984, (09) : 327 - 328
  • [6] Guidelines for the implementation of odour treatment
    Perryman, R.
    Chemistry and Industry (London), 1984, NO. 9 (09): : 327 - 328
  • [7] EVALUATING ADAPTIVE SMOOTHING MODELS - SOME GUIDELINES FOR IMPLEMENTATION
    FLIEDNER, EB
    FLORES, B
    MABERT, VA
    INTERNATIONAL JOURNAL OF PRODUCTION RESEARCH, 1986, 24 (04) : 955 - 970
  • [8] IMPLEMENTATION OF OUTPATIENT TREATMENT SCHEDULING GUIDELINES
    Baum, Jaida
    Phillips, Kelli
    ONCOLOGY NURSING FORUM, 2019, 46 (02)
  • [9] Dissemination and implementation of guidelines for the treatment of asthma
    Tan, W. C.
    Ait-Khaled, N.
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2006, 10 (07) : 710 - 716
  • [10] Survey content validation evaluating the dissemination and implementation of deprescribing guidelines
    Cheng, Chun Hei Justin
    Langford, Aili V.
    Gnjidic, Danijela
    Farrell, Barbara J.
    Schneider, Carl R.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2024, 134 (01) : 63 - 71